Viralgen Names Bayer's Angela Ochoa Chico CEO as Vanhove Exits
Image
San Sebastián – – October 19, 2026 -- Viralgen, the AAV gene therapy contract manufacturer owned by Bayer unit AskBio, has appointed Bayer executive Angela Ochoa Chico as chief executive effective January 1, 2027, replacing Jimmy Vanhove after four years in the role.
Vanhove moves to lead Bayer's U.S. pharmaceutical supply network expansion
Vanhove will lead the development and expansion of Bayer's U.S. Pharmaceutical Product Supply Network, based in New Albany, Ohio. He will join the Pharmaceuticals Division's Product Supply Leadership Team.